Anticancer activity of 1, 25-(OH)2D3 against human breast cancer cell lines by targeting Ras/MEK/ERK pathway
Wei Zheng,1 Lin Cao,2 Linna Ouyang,1 Qian Zhang,3 Bofeng Duan,1 Wei Zhou,4 Shan Chen,5 Wei Peng,1 Yi Xie,1 Qing Fan,6 Daoxing Gong7 1Department of Thyroid and Breast Surgery, The Third People’s Hospital of Shenzhen, Shenzhen, Guangdong 518112, China; 2Department of Breast Surgery, Maternal...
Main Authors: | Zheng W, Cao L, Ouyang L, Zhang Q, Duan B, Zhou W, Chen S, Peng W, Xie Y, Fan Q, Gong D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-01-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/anticancer-activity-of-1-25-oh2d3-against-human-breast-cancer-cell-lin-peer-reviewed-article-OTT |
Similar Items
-
The MEK/ERK Module Is Reprogrammed in Remodeling Adult Cardiomyocytes
by: Kubin Thomas, et al.
Published: (2020-09-01) -
Ras/Raf/MEK/ERK pathway activation in childhood acute lymphoblastic leukemia and its therapeutic targeting
by: Thomas eKnight, et al.
Published: (2014-06-01) -
A Role for K-ras in Conferring Resistance to the MEK Inhibitor, CI-1040
by: Yuli Wangab, et al.
Published: (2005-04-01) -
Polymorphisms in RAS/RAF/MEK/ERK Pathway Are Associated with Gastric Cancer
by: Patricio Gonzalez-Hormazabal, et al.
Published: (2018-12-01) -
Oxymatrine Inhibits Proliferation and Migration of Vulvar Squamous Cell Carcinoma Cells via Attenuation of the RAS/RAF/MEK/ERK Pathway
by: Wang Y, et al.
Published: (2020-03-01)